{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:49Z","timestamp":1792794589902,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Head For the Cure foundation to the Hermelin Brain Tumor Center at Henry Ford Health","id":[{"id":"https:\/\/ror.org\/02kwnkm68","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient-reported outcomes (PROs) are crucial for guiding patient care and maintaining quality of life This study assesses the feasibility of computer-based adaptations of the Patient-Reported Outcomes Measurement Information System (PROMIS) in a clinical setting and compares its outcomes with the EORTC-QLQ-C30 and EORTC-BN20 questionnaires. Validated, modular computer adaptive testing might reduce patient survey burden and provide physicians with more precise PROs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Newly diagnosed glioblastoma (GBM) patients were prospectively enrolled prior to radiation to evaluate feasibility. PROMIS modules were selected to reflect EORTC-QLQ-C30 and EORTC-BN20 domains, including anxiety, depression, fatigue, physical function, sleep disturbance, social satisfaction, cognitive ability, and global health. Patients completed both EORTC and PROMIS questionnaires electronically, preceding descriptive analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-three patients with 124 responses were analyzed. 31 patients completed surveys before or within 14 days of radiation, and 12 were outside the radiation window, yielding 60 completed surveys. Median completion times for the EORTC-QLQ-C30 and EORTC-BN20 were 4.77 (range: 2.05-18.6) and 2.63 (range: 1.17-24.83) min, respectively. For most PROMIS modules, completion times ranged from 0.6 to 1 min (range: 0.15-7.77), while global health took a median of 2.35 min (range: 1.02-21.12), The average time to completion was 8.65 min (range: 3.32-66.01). For most variables, PROMIS and EORTC-QLQ-C30 showed strong to moderate correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PROMIS measures correlated well with EORTC instruments, making them a suitable tool for evaluating patients with GBM. Response times were generally short, but variability suggested that low computer literacy, limited internet access, and disease burden may affect involvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag055","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:50:59Z","timestamp":1772283059000},"source":"Crossref","is-referenced-by-count":1,"title":["Electronic assessment of health-related quality of life in glioblastoma patients using the EORTC-QLQ-C30\/EORTC-BN20 and the PROMIS system in clinical practice"],"prefix":"10.1093","volume":"8","author":[{"given":"Tobias","family":"Walbert","sequence":"first","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwasoo","family":"Shin","sequence":"additional","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonni","family":"Schultz","sequence":"additional","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nerenz","sequence":"additional","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Snyder","sequence":"additional","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Josh","family":"Mohn","sequence":"additional","affiliation":[{"name":"Henry Ford Health Department of Neurology and Neurosurgery, Wayne State University and Michigan State University, Detroit (T.W.);"},{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit (H.S., L.S.);"},{"name":"Department of Neurosurgery, Center for Health Policy and Health Services Research, Henry Ford Health, Detroit (D.N.); Henry Ford Health Department of Neurology and Neurosurgery, Michigan State University, Detroit (J.M.S.); Department of Neurology, Henry Ford Health, Detroit (D.J.M)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2026041908165859300_vdag055-B1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026041908165859300_vdag055-B2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/neuonc\/noy164","article-title":"Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland","volume":"21","author":"Korja","year":"2019","journal-title":"Neuro Oncol"},{"key":"2026041908165859300_vdag055-B3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/neuonc\/noac198","article-title":"National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026041908165859300_vdag055-B4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/neuonc\/nov166","article-title":"The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms","volume":"18","author":"Armstrong","year":"2016","journal-title":"Neuro Oncol"},{"key":"2026041908165859300_vdag055-B5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/nop\/npae056","article-title":"Prospective assessment of end-of-life symptoms and quality of life in patients with high-grade glioma","volume":"11","author":"Walbert","year":"2024","journal-title":"Neurooncol Pract"},{"key":"2026041908165859300_vdag055-B6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/CCO.0000000000001078","article-title":"Patient-reported outcomes in neuro-oncology","volume":"36","author":"Scheepens","year":"2024","journal-title":"Curr Opin Oncol"},{"key":"2026041908165859300_vdag055-B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"2026041908165859300_vdag055-B8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1586\/erp.11.66","article-title":"The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review","volume":"11","author":"Leung","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2026041908165859300_vdag055-B9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/nop\/npae125","article-title":"Validation of the EORTC QLQ-C30 and QLQ-BN20, including WHO performance status interrater reliability, for evaluation of patients with intracranial meningiomas","volume":"12","author":"Nilsson","year":"2025","journal-title":"Neurooncol Pract"},{"key":"2026041908165859300_vdag055-B10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","article-title":"An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients","volume":"46","author":"Taphoorn","year":"2010","journal-title":"Eur J Cancer"},{"key":"2026041908165859300_vdag055-B11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jclinepi.2010.04.012","article-title":"Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)","volume":"63","author":"Rothrock","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2026041908165859300_vdag055-B12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fneur.2019.00212","article-title":"Health related quality of life in adult low and high-grade glioma patients using the National Institutes of Health Patient Reported Outcomes Measurement Information System (PROMIS) and neuro-QOL assessments","volume":"10","author":"Gabel","year":"2019","journal-title":"Front Neurol"},{"key":"2026041908165859300_vdag055-B13","author":"Computer Adaptive Tests (CATs)","year":"2025"},{"key":"2026041908165859300_vdag055-B14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-016-2314-7","article-title":"First use of Patient Reported Outcomes Measurement Information System (PROMIS) measures in adults with neurofibromatosis","volume":"131","author":"Talaei-Khoei","year":"2017","journal-title":"J Neurooncol"},{"key":"2026041908165859300_vdag055-B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.surg.2017.04.030","article-title":"Health-related quality of life in MEN1 patients compared with other chronic conditions and the United States general population","volume":"163","author":"Peipert","year":"2018","journal-title":"Surgery"},{"key":"2026041908165859300_vdag055-B16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/AJP.0000000000000955","article-title":"PROMIS neuropathic and nociceptive pain quality in musculoskeletal pain presentations","volume":"37","author":"Vaughan","year":"2021","journal-title":"Clin J Pain"},{"key":"2026041908165859300_vdag055-B17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11136-019-02164-2","article-title":"Comparative study of PROMIS(\u24c7) self-efficacy for managing chronic conditions across chronic neurologic disorders","volume":"28","author":"Shulman","year":"2019","journal-title":"Qual Life Res"},{"key":"2026041908165859300_vdag055-B18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cnur.2015.07.009","article-title":"Validation of the National Institutes of Health Patient-Reported Outcomes Measurement Information System survey as a quality-of-life instrument for patients with malignant brain tumors and their caregivers","volume":"50","author":"Romero","year":"2015","journal-title":"Nurs Clin North Am"},{"key":"2026041908165859300_vdag055-B19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11060-024-04627-0","article-title":"Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients","volume":"167","author":"Chakravarti","year":"2024","journal-title":"J Neurooncol"},{"key":"2026041908165859300_vdag055-B20","author":"Life EQo"},{"key":"2026041908165859300_vdag055-B21","first-page":"567","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd ed."},{"key":"2026041908165859300_vdag055-B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nop\/npv062","article-title":"Clinical outcome assessments in neuro-oncology: a regulatory perspective","volume":"3","author":"Sul","year":"2016","journal-title":"Neurooncol Pract"},{"key":"2026041908165859300_vdag055-B23","doi-asserted-by":"publisher","first-page":"8860","DOI":"10.1002\/cam4.5635","article-title":"Real time patient-reported outcome measures in patients with cancer: early experience within an integrated health system","volume":"12","author":"Tam","year":"2023","journal-title":"Cancer Med"},{"key":"2026041908165859300_vdag055-B24","author":"HealthMeasures","year":"2024"},{"key":"2026041908165859300_vdag055-B25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/cncr.29104","article-title":"Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care","volume":"121","author":"Wagner","year":"2015","journal-title":"Cancer"},{"key":"2026041908165859300_vdag055-B26","doi-asserted-by":"publisher","first-page":"vdad096","DOI":"10.1093\/noajnl\/vdad096","article-title":"Development of a core outcome set for use in adult primary glioma phase III interventional trials: a mixed methods study","volume":"5","author":"Retzer","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026041908165859300_vdag055-B27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00520-020-05801-6","article-title":"Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review","volume":"29","author":"Tran","year":"2021","journal-title":"Support Care Cancer"},{"key":"2026041908165859300_vdag055-B28","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/pon.4825","article-title":"PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers: experience from a randomized trial","volume":"27","author":"Sikorskii","year":"2018","journal-title":"Psychooncology"},{"key":"2026041908165859300_vdag055-B29","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1634\/theoncologist.2019-0348","article-title":"The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the \u201creal-world\u201d: results from the population-based PROFILES registry","volume":"25","author":"Husson","year":"2020","journal-title":"Oncologist"},{"key":"2026041908165859300_vdag055-B30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/OP.23.00720","article-title":"Differences in patient-reported outcome measures in patients with cancer six months before death","volume":"21","author":"Tam","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"2026041908165859300_vdag055-B31","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1136\/bmjspcare-2020-002699","article-title":"Glioma patient-reported outcomes: patients and clinicians","volume":"13","author":"Peeters","year":"2023","journal-title":"BMJ Support Palliat Care"},{"key":"2026041908165859300_vdag055-B32","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s11136-017-1648-8","article-title":"Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients","volume":"26","author":"Dirven","year":"2017","journal-title":"Qual Life Res"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag055\/67197918\/vdag055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag055\/67197918\/vdag055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag055\/67197918\/vdag055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:17:05Z","timestamp":1776601025000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag055\/8503438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag055","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag055"}}